CONMED announces agreement to acquire Biorez, Inc.

Conmed Corporation announced an agreement to acquire privately held Biorez.

Biorez is a medical device start-up based in New Haven, Connecticut and is focused on advancing the healing of soft tissue using its BioBrace Implant technology. The BioBrace implant is an innovative bioinductive scaffold that is intended to reinforce soft tissue where weakness exists and facilitate healing. BioBrace is cleared for use by the FDA in multiple product sizes.

“The addition of Biorez and its BioBrace platform represents an important step forward for our sports medicine portfolio,” commented Curt R. Hartman, Conmed’s chair of the board, President, and chief executive officer. “BioBrace fits seamlessly into our existing suite of products, and we are excited to advance the next generation of healing in sports medicine.”

Kevin Rocco, chief executive officer of Biorez added, “I am proud of the Biorez team for developing an innovative healing solution that provides a new treatment option for surgeons and patients. We are thrilled to join Conmed to accelerate the growth of our technology on a global scale.”